Lymphogranuloma venereum differential diagnosis: Difference between revisions

Jump to navigation Jump to search
m (Changes made per Mahshid's request)
 
(4 intermediate revisions by one other user not shown)
Line 4: Line 4:


==Overview==
==Overview==
Lymphogranuloma venereum (LGV) must be differentiated from other diseases that cause genital ulcers, [[lymphadenopathy]], or [[proctocolitis]] including [[syphilis]], [[Herpes simplex]], [[Behçet's disease]], [[chancroid]], [[donovanosis]], [[fixed drug eruption]], [[psoriasis]], chlamydial diseases caused by ''C. trachomatis'' [[serovars]] D-K, and diseases characterized with [[colitis]]. [[Sexually transmitted diseases]] characterized as [[genital ulcer diseases]] will present with the most similar symptoms to LGV.


==Differentiating Lymphoranuloma Venereum from Other Diseases==
==Differentiating Lymphogranuloma Venereum from Other Diseases==
Lymphogranuloma venereum (LGV) must be differentiated from other diseases that cause genital ulcers, [[lymphadenopathy]], or [[proctocolitis]] including:<ref name="pmid12081191">{{cite journal| author=Mabey D, Peeling RW| title=Lymphogranuloma venereum. | journal=Sex Transm Infect | year= 2002 | volume= 78 | issue= 2 | pages= 90-2 | pmid=12081191 | doi= | pmc=PMC1744436 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12081191  }} </ref>
*[[Syphilis]]
*[[Herpes simplex]]
*[[Behçet's disease]]
*[[Chancroid]]
*[[Donovanosis]]
*[[Fixed drug eruption]]
*[[Psoriasis]]
*Chlamydial diseases caused by ''C. trachomatis'' [[serovars]] D-K
*Diseases characterized with [[colitis]]
 
[[Sexually transmitted diseases]] characterized as [[genital ulcer diseases]] may present with similar manifestations and lesion characteristics. A diagnosis based only on the patient’s medical history and physical examination frequently is inaccurate. Patients who have genital, anal, or perianal ulcers should be evaluated with laboratory tests to make a definitive diagnosis.<ref name="GUDCDC">2015 Sexually Transmitted Diseases Treatment Guidelines. Centers for Disease Control and Prevention (June 4, 2015). http://www.cdc.gov/std/tg2015/genital-ulcers.htm Accessed February 18, 2016.</ref>
{| style="font-size: 90%;"
! style="background: #4479BA; padding: 5px 5px;" rowspan="2" | {{fontcolor|#FFFFFF|Clinical Characteristic}}
! style="background: #4479BA; padding: 5px 5px;" colspan="5" | {{fontcolor|#FFFFFF|Sexually Transmitted Disease}}
|-
! style="background: #4479BA; padding: 5px 5px; width: 200px;" | {{fontcolor|#FFFFFF|Chancroid}}
! style="background: #4479BA; padding: 5px 5px; width: 200px;" | {{fontcolor|#FFFFFF|Genital Herpes}}
! style="background: #4479BA; padding: 5px 5px; width: 200px;" | {{fontcolor|#FFFFFF|Donovanosis}}
! style="background: #4479BA; padding: 5px 5px; width: 200px;" | {{fontcolor|#FFFFFF|LGV}}
! style="background: #4479BA; padding: 5px 5px; width: 200px;" | {{fontcolor|#FFFFFF|Syphilis}}
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Cause'''
| style="padding: 5px 5px; background: #F5F5F5;" | ''[[Haemophilus ducreyi]]''
| style="padding: 5px 5px; background: #F5F5F5;" | [[Herpes Simplex Virus]] (HSV-1 & HSV-2)
| style="padding: 5px 5px; background: #F5F5F5;" | ''[[Klebsiella|Klebsiella granulomatis]]''
| style="padding: 5px 5px; background: #F5F5F5;" | ''[[Chlamydia trachomatis]]'' serovars L1, L2, or L3
| style="padding: 5px 5px; background: #F5F5F5;" | ''[[Treponema pallidum]]''
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Lesion Type'''
| style="padding: 5px 5px; background: #F5F5F5;" | [[Papule]] evolving to ulcer
| style="padding: 5px 5px; background: #F5F5F5;" | [[Vesicle]] evolving to [[ulcer]]
| style="padding: 5px 5px; background: #F5F5F5;" | Ulcer progressing to [[granuloma]]
| style="padding: 5px 5px; background: #F5F5F5;" | Self-limited papule or ulcer
| style="padding: 5px 5px; background: #F5F5F5;" | Papule evolving to ulcer
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Lesion Border'''
| style="padding: 5px 5px; background: #F5F5F5;" | Crater with irregular, sharp margins
| style="padding: 5px 5px; background: #F5F5F5;" | Circular, sharp margins on erythematous base
| style="padding: 5px 5px; background: #F5F5F5;" | Friable base with sharp, raised, rolled margin
| style="padding: 5px 5px; background: #F5F5F5;" | Shallow, smooth border
| style="padding: 5px 5px; background: #F5F5F5;" | Crater with raised edges, smooth margins
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Lesion Distribution'''
| style="padding: 5px 5px; background: #F5F5F5;" | Single or multiple
| style="padding: 5px 5px; background: #F5F5F5;" | Multiple, in group/crop
| style="padding: 5px 5px; background: #F5F5F5;" | Single or multiple
| style="padding: 5px 5px; background: #F5F5F5;" | Single or herpetiform
| style="padding: 5px 5px; background: #F5F5F5;" | Multiple
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Lesion Texture'''
| style="padding: 5px 5px; background: #F5F5F5;" | Soft
| style="padding: 5px 5px; background: #F5F5F5;" | [[Umbilicated lesions|Umbilicated]]
| style="padding: 5px 5px; background: #F5F5F5;" | Granulomatous
| style="padding: 5px 5px; background: #F5F5F5;" | Firm bump
| style="padding: 5px 5px; background: #F5F5F5;" | Indurated
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Lesion Tenderness'''
| style="padding: 5px 5px; background: #F5F5F5;" | Present
| style="padding: 5px 5px; background: #F5F5F5;" | Present
| style="padding: 5px 5px; background: #F5F5F5;" | Absent
| style="padding: 5px 5px; background: #F5F5F5;" | Absent
| style="padding: 5px 5px; background: #F5F5F5;" | Absent
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Lesion Exudate'''
| style="padding: 5px 5px; background: #F5F5F5;" | Grey/yellow purulent exudate
| style="padding: 5px 5px; background: #F5F5F5;" | Non-exudative
| style="padding: 5px 5px; background: #F5F5F5;" | Non-exudative but bleeds easily
| style="padding: 5px 5px; background: #F5F5F5;" | Non-exudative
| style="padding: 5px 5px; background: #F5F5F5;" | Non-exudative; non-fluctuant
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Lymphadenopathy'''
| style="padding: 5px 5px; background: #F5F5F5;" | Present and tender in approx. half of patients (typically unilateral)
| style="padding: 5px 5px; background: #F5F5F5;" | Present and tender
| style="padding: 5px 5px; background: #F5F5F5;" | Absent from primary infection; pseudobuboes may occur
| style="padding: 5px 5px; background: #F5F5F5;" | Present and tender
| style="padding: 5px 5px; background: #F5F5F5;" | Present and non-tender (uni- or bilateral)
|}


==References==
==References==
Line 14: Line 93:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Gynecology]]
[[Category:Gynecology]]
[[Category:Infectious disease]]
 
[[Category:Bacterial diseases]]
[[Category:Bacterial diseases]]

Latest revision as of 17:59, 18 September 2017

Lymphogranuloma venereum Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Classification

Differentiating Lymphogranuloma venereum from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphogranuloma venereum differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphogranuloma venereum differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphogranuloma venereum differential diagnosis

CDC on Lymphogranuloma venereum differential diagnosis

Lymphogranuloma venereum differential diagnosis in the news

Blogs on Lymphogranuloma venereum differential diagnosis

Directions to Hospitals Treating Lymphogranuloma venereum

Risk calculators and risk factors for Lymphogranuloma venereum differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nate Michalak, B.A.

Overview

Lymphogranuloma venereum (LGV) must be differentiated from other diseases that cause genital ulcers, lymphadenopathy, or proctocolitis including syphilis, Herpes simplex, Behçet's disease, chancroid, donovanosis, fixed drug eruption, psoriasis, chlamydial diseases caused by C. trachomatis serovars D-K, and diseases characterized with colitis. Sexually transmitted diseases characterized as genital ulcer diseases will present with the most similar symptoms to LGV.

Differentiating Lymphogranuloma Venereum from Other Diseases

Lymphogranuloma venereum (LGV) must be differentiated from other diseases that cause genital ulcers, lymphadenopathy, or proctocolitis including:[1]

Sexually transmitted diseases characterized as genital ulcer diseases may present with similar manifestations and lesion characteristics. A diagnosis based only on the patient’s medical history and physical examination frequently is inaccurate. Patients who have genital, anal, or perianal ulcers should be evaluated with laboratory tests to make a definitive diagnosis.[2]

Clinical Characteristic Sexually Transmitted Disease
Chancroid Genital Herpes Donovanosis LGV Syphilis
Cause Haemophilus ducreyi Herpes Simplex Virus (HSV-1 & HSV-2) Klebsiella granulomatis Chlamydia trachomatis serovars L1, L2, or L3 Treponema pallidum
Lesion Type Papule evolving to ulcer Vesicle evolving to ulcer Ulcer progressing to granuloma Self-limited papule or ulcer Papule evolving to ulcer
Lesion Border Crater with irregular, sharp margins Circular, sharp margins on erythematous base Friable base with sharp, raised, rolled margin Shallow, smooth border Crater with raised edges, smooth margins
Lesion Distribution Single or multiple Multiple, in group/crop Single or multiple Single or herpetiform Multiple
Lesion Texture Soft Umbilicated Granulomatous Firm bump Indurated
Lesion Tenderness Present Present Absent Absent Absent
Lesion Exudate Grey/yellow purulent exudate Non-exudative Non-exudative but bleeds easily Non-exudative Non-exudative; non-fluctuant
Lymphadenopathy Present and tender in approx. half of patients (typically unilateral) Present and tender Absent from primary infection; pseudobuboes may occur Present and tender Present and non-tender (uni- or bilateral)

References

  1. Mabey D, Peeling RW (2002). "Lymphogranuloma venereum". Sex Transm Infect. 78 (2): 90–2. PMC 1744436. PMID 12081191.
  2. 2015 Sexually Transmitted Diseases Treatment Guidelines. Centers for Disease Control and Prevention (June 4, 2015). http://www.cdc.gov/std/tg2015/genital-ulcers.htm Accessed February 18, 2016.

Template:WH Template:WS